GILEAD

GILEAD

Displaying 10 out of 38 results

  1. FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news co

    Russian firm seeks to produce COVID-19 drug without patent, Vedomosti reports

    Russian drugmaker Pharmasyntez has asked the Kremlin for permission to produce a generic version of U.S. firm Gilead Sciences's COVID-19 ...
  2. FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news co

    Nations reviewing remedesivir should consider COVID-19 trial flop: WHO

    The World Health Organization is preparing its guidelines on the use of the drug remdesivir to treat COVID-19, and should be able to release it in ...
  3. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavir

    Gilead shares rise after United States approves remdesivir as COVID-19 drug

    Shares of Gilead Sciences Inc rose 6per cent on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for ...
  4. An ampule of Gilead Sciences COVID-19 antiviral remdesivir

    Gilead's remdesivir gets US FDA approval for hospitalised COVID-19 patients

    The US Food and Drug Administration on Thursday (Oct 22) approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients ...
  5. The spread of the coronavirus disease (COVID-19) in Hamburg

    EU urged to review remdesivir supply deal after COVID-19 trial results

    The European Union should renegotiate a 1 billion euro (US$1.2 billion) contract it sealed last week with Gilead for a six-month supply of the ...
  6. FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news co

    Analysis: Sales of first big COVID-19 drug, remdesivir, may disappoint

    Investors betting on big profits from COVID-19 treatments may get an unwelcome surprise when Gilead Sciences Inc reports quarterly results this ...
  7. An ampule of Ebola drug Remdesivir

    Europe buys Gilead's remdesivir for 500,000 COVID-19 patients amid supply worries

    Gilead Sciences said on Thursday it had agreed to sell Europe up to 500,0000 courses of its antiviral drug remdesivir, as the continent scrambles ...
  8. Gilead Sciences Inc pharmaceutical company

    Gilead to pay US$97 million to settle US kickback probe

    Gilead Sciences Inc has agreed to pay US$97 million to resolve U.S. government claims it used a purportedly independent charity to pay illegal ...
  9. FILE PHOTO: Gilead Sciences Inc pharmaceutical company in California, U.S.

    Gilead's shares rise after US$21 billion deal for Immunomedics

    Shares of Gilead Sciences Inc rose 3.2per cent on Monday, reversing their premarket losses as investors shrugged off concerns over the steep ...
  10. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavir

    Gilead nears deal to buy Immunomedics for more than US$20 billion: Report

    Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for US$21 billion in a deal that would further expand Gilead's ...